NCT02021123View on ClinicalTrials.gov

Anidulafungin Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ADOPT)

PHASE4CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Obesity Morbid
Interventions
DRUG

Anidulafungin 100mg single dose iv

Anidulafungin 100mg single dose iv pre-surgery (gastric bypass)

Trial Locations (2)

Unknown

Radboud University Medical Center, Nijmegen

St. Antonius hospital, Nieuwegein

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT02021123 - Anidulafungin Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ADOPT) | Biotech Hunter | Biotech Hunter